Your browser doesn't support javascript.
loading
The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
Wan, Xu; Zheng, Xiaoyao; Pang, Xiaoying; Zhang, Zheming; Jing, Tao; Xu, Wei; Zhang, Qizhi.
  • Wan X; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, PR China.
  • Zheng X; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, PR China.
  • Pang X; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, PR China.
  • Zhang Z; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, PR China.
  • Jing T; Shanghai Zhangjiang Medicine Valley Public Service Platform Co., Ltd., Shanghai 201203, PR China.
  • Xu W; Shanghai Zhangjiang Medicine Valley Public Service Platform Co., Ltd., Shanghai 201203, PR China.
  • Zhang Q; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, PR China. Electronic address: qzzhang@fudan.edu.cn.
Int J Pharm ; 484(1-2): 16-28, 2015 Apr 30.
Article en En | MEDLINE | ID: mdl-25700543

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinazolinas / Albúmina Sérica / Nanopartículas / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinazolinas / Albúmina Sérica / Nanopartículas / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2015 Tipo del documento: Article